Bank of Montreal’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-186,080
| Closed | -$12.7M | – | 4597 |
|
|
2022
Q3 | $12.7M | Buy |
+186,080
| New | +$10.3M | 0.01% | 877 |
|
|
2021
Q2 | – | Sell |
-96
| Closed | -$4K | – | 5348 |
|
|
2021
Q1 | $4K | Sell |
96
-707
| -88% | -$32.5K | ﹤0.01% | 4788 |
|
|
2020
Q4 | $36K | Sell |
803
-507
| -39% | -$25K | ﹤0.01% | 4122 |
|
|
2020
Q3 | $80K | Buy |
1,310
+703
| +116% | +$44.7K | ﹤0.01% | 3210 |
|
|
2020
Q2 | $43K | Sell |
607
-167
| -22% | -$11.5K | ﹤0.01% | 3504 |
|
|
2020
Q1 | $39K | Sell |
774
-7,973
| -91% | -$534K | ﹤0.01% | 2996 |
|
|
2019
Q4 | $695K | Buy |
8,747
+117
| +1% | +$6.93K | ﹤0.01% | 2483 |
|
|
2019
Q3 | $419K | Buy |
8,630
+2,789
| +48% | +$145K | ﹤0.01% | 2505 |
|
|
2019
Q2 | $307K | Buy |
5,841
+4,966
| +568% | +$285K | ﹤0.01% | 2704 |
|
|
2019
Q1 | $47K | Sell |
875
-707
| -45% | -$34.7K | ﹤0.01% | 3362 |
|
|
2018
Q4 | $65K | Buy |
1,582
+605
| +62% | +$22.7K | ﹤0.01% | 3173 |
|
|
2018
Q3 | $37K | Sell |
977
-10
| -1% | -$443 | ﹤0.01% | 3512 |
|
|
2018
Q2 | $44K | Buy |
987
+237
| +32% | +$10.8K | ﹤0.01% | 3465 |
|
|
2018
Q1 | $36K | Sell |
750
-4,300
| -85% | -$240K | ﹤0.01% | 3365 |
|
|
2017
Q4 | $199K | Sell |
5,050
-6,850
| -58% | -$256K | ﹤0.01% | 2683 |
|
|
2017
Q3 | $369K | Sell |
11,900
-3,500
| -23% | -$98.4K | ﹤0.01% | 2410 |
|
|
2017
Q2 | $421K | Sell |
15,400
-800
| -5% | -$23.8K | ﹤0.01% | 2346 |
|
|
2017
Q1 | $597K | Buy |
+16,200
| New | +$408K | ﹤0.01% | 2050 |
|
|
2016
Q1 | – | Sell |
-2,500
| Closed | -$81K | – | 4463 |
|
|
2015
Q4 | $81K | Sell |
2,500
-1,500
| -38% | -$65K | ﹤0.01% | 2858 |
|
|
2015
Q3 | $169K | Buy |
+4,000
| New | +$189K | ﹤0.01% | 2343 |
|
Other funds holding GBT
Bank of Montreal's GBT Position: Q4 2022 in Review
Bank of Montreal sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 186,080 shares — an estimated $12.7M sold.
Bank of Montreal first reported a position in GBT in Q3 2015 and held it in 20 quarters. The position peaked at $12.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Bank of Montreal reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Bank of Montreal sold 186,080 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $12.7M.
- Bank of Montreal first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 20 quarters.
- Bank of Montreal's Global Blood Therapeutics, Inc. position peaked at $12.7M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.